Drugs / BPI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00462904 | Apr 2006 → Nov 2007 | — | University of Texas Southwestern Medical Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BPI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00462904 ↗ |
| Modality | Protein / enzyme biologic | “a protein called BPI that is naturally made by the body's white blood cells to fight infection” NCT00462904 ↗ |
| Route | Intravenous | “BPI will be give IV with an initial bolus given over 30 minutes and then a continuous infusion for the next 47.5 hours” NCT00462904 ↗ |